Recursion Pharmaceuticals, Inc.

RXRX · NASDAQ

Recursion Pharmaceuticals, Inc.RXRX · NASDAQ

Regular Market · Oct 30, 04:42 PM

$3.89-$0.36 -8.37%

High: —
Low: —
Volume: —

Loading chart…

Ask Alva about RXRX

Recursion Pharmaceuticals, Inc.

RXRX · Biotechnology

3.89 USD

-0.36 (-8.37%)

Regular Market

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Recursion Pharmaceuticals, Inc.

RXRX · NASDAQ

Regular Market

3.89 USD

-0.36 (-8.37%)

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Unusual Price Movement

RXRX remained lower in the broad technology-led risk-off selloff.

No new catalyst: RXRX was down about 5.1%, following the earlier premarket decline as the Nasdaq fell 2.2% and the S&P 500 fell 1.2% while volatility jumped. Intel's record-scale selloff added to the technology risk-off tone. RXRX's peer group was mixed, leaving the broad tape as the main driver.

Unusual Price Movement

RXRX remained lower in the broad technology-led risk-off selloff.

Sources:

Nasdaq 100 sinks 2.8% at the open as S&P 500 falls 1.2%

Intel shares plunge 29%, on pace for their sharpest one-day decline on record

Ask Alva anything. @ for context, / for skills

Ask Alva about RXRX

RXRX remained lower in the broad technology-led risk-off selloff. ⓘ

RXRX remained lower in the broad technology-led risk-off selloff. ⓘ

RXRX remained lower in the broad technology-led risk-off selloff.

RXRX remained lower in the broad technology-led risk-off selloff.